Overview

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of four concentrations of DE-117 ophthalmic solution.
Phase:
Phase 2
Details
Lead Sponsor:
Santen Inc.
Treatments:
Latanoprost
Ophthalmic Solutions
Pharmaceutical Solutions